COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

NCT04787510 · clinicaltrials.gov ↗

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

SARS-COV2 Infection
COVID-19 Disease
Hospitalized Patients

Interventions

DRUG: low molecular weight Heparin as standard of care treatment

Sponsor

University Hospital, Ioannina

Collaborators

[object Object]